| 6. | Maurer, M. and Redegeld, F., editors: The pharmacological modulation of mast cells and basophils. Vol. 778; 1-176 European Journal of Pharmacology, Elsevier, 2016 |
b.006
The pharmacological modulation of mast cells and basophils Read More »
| 88. | Saluja, R., Ketelaar, M. E., Hawro, T., Church, M. K., Maurer, M., and Nawijn, M. C.: The role of the IL-33/IL-1RL1 axis in mast cell and basophil activation in allergic disorders. Mol. Immunol. 2014: 63; 80-85. IF: 2.97 |
r.088
| 89. | Harvima, I. T., Levi-Schaffer, F., Draber, P., Friedman, S., Polakovicova, I., Gibbs, B. F., Blank, U., Nilsson, G. and Maurer, M.: Molecular targets on mast cells and basophils for novel therapies. J. Allergy Clin. Immunol. 2014: 134; 530-544. IF: 11.47 |
Molecular targets on mast cells and basophils for novel therapies Read More »
| 13. | Bousquet, J., Anto, J. M., Bachert, C., Bousquet, P. J., Colombo, P., Crameri, R., Daeron, M., Fokkens, W., Leynaert, B., Lahoz, C., Maurer, M., Passalacqua, G., Valenta, R., van Hage, M., and van Ree, R.: Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GA²LEN project. Allergy 2006: 61; 671-680. IF 5.33 |
r.013
| 159 | Nullens, S., Sabato, V., Faber, M., Leysen, J., Bridts, C. H., de Clerck, L. S., Falcone, F., Maurer, M.and Ebo, D. G.+: Basophilic histamine content and release during venom immunotherapy: insights by flow cytometry. Cytom. Part B – Clin. CY 2013: 84; 173-178. IF: 2.28 |